6	CD	6	6	6	N	O
ADVERSE	JJ	adverse	adverse	advers	N	O
REACTIONS	NN	reactions	reaction	reaction	N	O

Clinically	RB	clinically	clinically	clinic	N	O
significant	JJ	significant	significant	signific	N	O
adverse	JJ	adverse	adverse	advers	N	O
reactions	NNS	reactions	reaction	reaction	N	O
that	WDT	that	that	that	N	O
appear	VBP	appear	appear	appear	N	O
in	IN	in	in	in	N	O
other	JJ	other	other	other	N	O
sections	NNS	sections	section	section	N	O
of	IN	of	of	of	N	O
the	DT	the	the	the	N	O
labeling	VBG	labeling	labeling	label	N	O
include	VBP	include	include	includ	N	O
the	DT	the	the	the	N	O
following	NN	following	following	follow	N	O
:	:	:	:	:	N	O

Somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
or	CC	or	or	or	N	O
Sedation	NNP	sedation	sedation	sedat	Y	B-AdverseReaction
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.1	CD	5.1	5.1	5.1	N	O
)]	NN	)]	)]	)]	N	O

Potentiation	NN	potentiation	potentiation	potenti	N	B-AdverseReaction
of	IN	of	of	of	N	I-AdverseReaction
Sedation	NN	sedation	sedation	sedat	Y	I-AdverseReaction
from	IN	from	from	from	N	O
Concomitant	NNP	concomitant	concomitant	concomit	N	O
Use	NNP	use	use	use	N	O
with	IN	with	with	with	N	O
Central	NNP	central	central	central	N	O
Nervous	NNP	nervous	nervous	nervou	Y	O
System	NNP	system	system	system	N	O
Depressants	NNP	depressants	depressant	depress	N	O
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.2	CD	5.2	5.2	5.2	N	O
)]	NN	)]	)]	)]	N	O

Withdrawal	NNP	withdrawal	withdrawal	withdraw	N	O
Symptoms	NNP	symptoms	symptom	symptom	N	O
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.3	CD	5.3	5.3	5.3	N	O
)]	NN	)]	)]	)]	N	O

Serious	JJ	serious	serious	seriou	N	B-Severity
Dermatological	NNP	dermatological	dermatological	dermatolog	N	B-AdverseReaction
Reactions	NNP	reactions	reaction	reaction	N	I-AdverseReaction
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Contraindications	NNP	contraindications	contraindication	contraind	N	O
(	(	(	(	(	N	O
4	CD	4	4	4	N	O
)	)	)	)	)	N	O
,	,	,	,	,	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.4	CD	5.4	5.4	5.4	N	O
)]	NN	)]	)]	)]	N	O

Physical	JJ	physical	physical	physic	N	B-AdverseReaction
and	CC	and	and	and	N	O
Psychological	JJ	psychological	psychological	psycholog	N	B-AdverseReaction
Dependence	NNP	dependence	dependence	depend	Y	I-AdverseReaction
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.5	CD	5.5	5.5	5.5	N	O
)]	NN	)]	)]	)]	N	O

Suicidal	NNP	suicidal	suicidal	suicid	N	B-AdverseReaction
Behavior	NNP	behavior	behavior	behavior	N	I-AdverseReaction
and	CC	and	and	and	N	O
Ideation	NNP	ideation	ideation	ideat	N	I-AdverseReaction
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Warnings	NNP	warnings	warning	warn	N	O
and	CC	and	and	and	N	O
Precautions	NNP	precautions	precaution	precaut	N	O
(	(	(	(	(	N	O
5.6	CD	5.6	5.6	5.6	N	O
)]	NN	)]	)]	)]	N	O

EXCERPT	NN	excerpt	excerpt	excerpt	N	O
:	:	:	:	:	N	O
Adverse	JJ	adverse	adverse	advers	N	O
reactions	NNS	reactions	reaction	reaction	N	O
that	WDT	that	that	that	N	O
occurred	VBD	occurred	occurred	occur	N	O
at	IN	at	at	at	N	O
least	JJS	least	least	least	N	O
10%	CD	10%	10%	10%	N	O
more	JJR	more	more	more	N	O
frequently	RB	frequently	frequently	frequent	N	O
than	IN	than	than	than	N	O
placebo	NN	placebo	placebo	placebo	N	O
in	IN	in	in	in	N	O
any	DT	any	any	ani	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
dose	NN	dose	dose	dose	N	O
included	VBD	included	included	includ	N	O
constipation	NN	constipation	constipation	constip	Y	B-AdverseReaction
,	,	,	,	,	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
or	CC	or	or	or	N	O
sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
,	,	,	,	,	N	O
pyrexia	NN	pyrexia	pyrexia	pyrexia	Y	B-AdverseReaction
,	,	,	,	,	N	O
lethargy	NN	lethargy	lethargy	lethargi	Y	B-AdverseReaction
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
drooling	VBG	drooling	drooling	drool	Y	B-AdverseReaction
(	(	(	(	(	N	O
6.1	CD	6.1	6.1	6.1	N	O
)	)	)	)	)	N	O

To	TO	to	to	to	N	O

report	NN	report	report	report	N	O
SUSPECTED	NNP	suspected	suspected	suspect	N	O
ADVERSE	NNP	adverse	adverse	advers	N	O
REACTIONS	NNP	reactions	reaction	reaction	N	O
,	,	,	,	,	N	O
contact	NN	contact	contact	contact	N	O
Lundbeck	NNP	lundbeck	lundbeck	lundbeck	N	O
at	IN	at	at	at	N	O
1	CD	1	1	1	N	O
-	:	-	-	-	N	O
800	CD	800	800	800	N	O
-	:	-	-	-	N	O
455	CD	455	455	455	N	O
-	:	-	-	-	N	O
1141	CD	1141	1141	1141	N	O
or	CC	or	or	or	N	O
FDA	NNP	fda	fda	fda	N	O
at	IN	at	at	at	N	O
1	CD	1	1	1	N	O
-	:	-	-	-	N	O
800	CD	800	800	800	N	O
-	:	-	-	-	N	O
FDA	NNP	fda	fda	fda	N	O
-	:	-	-	-	N	O
1088	CD	1088	1088	1088	N	O
or	CC	or	or	or	N	O
www	VB	www	www	www	N	O
.	.	.	.	.	N	O
fda	NN	fda	fda	fda	N	O
.	.	.	.	.	N	O
gov	JJ	gov	gov	gov	N	O
medwatch	NN	medwatch	medwatch	medwatch	N	O
.	.	.	.	.	N	O

6.1	CD	6.1	6.1	6.1	N	O

Clinical	JJ	clinical	clinical	clinic	N	O
Trials	NNS	trials	trial	trial	N	O
Experience	NN	experience	experience	experi	N	O

Because	IN	because	because	becaus	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
are	VBP	are	are	are	N	O
conducted	VBN	conducted	conducted	conduct	N	O
under	IN	under	under	under	N	O
widely	RB	widely	widely	wide	N	O
varying	VBG	varying	varying	vari	N	O
conditions	NNS	conditions	condition	condit	N	O
,	,	,	,	,	N	O
adverse	JJ	adverse	adverse	advers	N	O
reaction	NN	reaction	reaction	reaction	N	O
rates	NNS	rates	rate	rate	N	O
observed	VBD	observed	observed	observ	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
of	IN	of	of	of	N	O
a	DT	a	a	a	N	O
drug	NN	drug	drug	drug	N	O
cannot	NN	cannot	cannot	cannot	N	O
be	VB	be	be	be	N	O
directly	RB	directly	directly	directli	N	O
compared	VBN	compared	compared	compar	N	O
to	TO	to	to	to	N	O
rates	NNS	rates	rate	rate	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
of	IN	of	of	of	N	O
another	DT	another	another	anoth	N	O
drug	NN	drug	drug	drug	N	O
and	CC	and	and	and	N	O
may	MD	may	may	may	N	O
not	RB	not	not	not	N	O
reflect	VB	reflect	reflect	reflect	N	O
the	DT	the	the	the	N	O
rates	NNS	rates	rate	rate	N	O
observed	VBD	observed	observed	observ	N	O
in	IN	in	in	in	N	O
practice	NN	practice	practice	practic	N	O
.	.	.	.	.	N	O

During	IN	during	during	dure	N	O
its	PRP$	its	it	it	N	O
development	NN	development	development	develop	N	O
for	IN	for	for	for	N	O
the	DT	the	the	the	N	O
adjunctive	JJ	adjunctive	adjunctive	adjunct	N	O
treatment	NN	treatment	treatment	treatment	N	O
of	IN	of	of	of	N	O
seizures	NNS	seizures	seizure	seizur	Y	O
associated	VBN	associated	associated	associ	N	O
with	IN	with	with	with	N	O
LGS	NNP	lgs	lgs	lg	N	O
,	,	,	,	,	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
was	VBD	was	wa	wa	N	O
administered	VBN	administered	administered	administ	N	O
to	TO	to	to	to	N	O
333	CD	333	333	333	N	O
healthy	JJ	healthy	healthy	healthi	N	O
volunteers	NNS	volunteers	volunteer	volunt	N	O
and	CC	and	and	and	N	O
300	CD	300	300	300	N	O
patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
a	DT	a	a	a	N	O
current	JJ	current	current	current	N	O
or	CC	or	or	or	N	O
prior	JJ	prior	prior	prior	N	O
diagnosis	NN	diagnosis	diagnosis	diagnosi	N	O
of	IN	of	of	of	N	O
LGS	NNP	lgs	lgs	lg	N	O
,	,	,	,	,	N	O
including	VBG	including	including	includ	N	O
197	CD	197	197	197	N	O
patients	NNS	patients	patient	patient	N	O
treated	VBD	treated	treated	treat	N	O
for	IN	for	for	for	N	O
12	CD	12	12	12	N	O
months	NNS	months	month	month	N	O
or	CC	or	or	or	N	O
more	JJR	more	more	more	N	O
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
conditions	NNS	conditions	condition	condit	N	O
and	CC	and	and	and	N	O
duration	NN	duration	duration	durat	N	O
of	IN	of	of	of	N	O
exposure	NN	exposure	exposure	exposur	N	O
varied	VBN	varied	varied	vari	N	O
greatly	RB	greatly	greatly	greatli	N	O
and	CC	and	and	and	N	O
included	VBD	included	included	includ	N	O
single	JJ	single	single	singl	N	O
-	:	-	-	-	N	O
and	CC	and	and	and	N	O
multiple	JJ	multiple	multiple	multipl	N	O
-	:	-	-	-	N	O
dose	JJ	dose	dose	dose	N	O
clinical	JJ	clinical	clinical	clinic	N	O
pharmacology	NN	pharmacology	pharmacology	pharmacolog	N	O
studies	NNS	studies	study	studi	N	O
in	IN	in	in	in	N	O
healthy	JJ	healthy	healthy	healthi	N	O
volunteers	NNS	volunteers	volunteer	volunt	N	O
and	CC	and	and	and	N	O
two	CD	two	two	two	N	O
double	JJ	double	double	doubl	N	O
-	:	-	-	-	N	O
blind	NN	blind	blind	blind	Y	O
studies	NNS	studies	study	studi	N	O
in	IN	in	in	in	N	O
patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
LGS	NNP	lgs	lgs	lg	N	O
(	(	(	(	(	N	O
Study	NNP	study	study	studi	N	O
1	CD	1	1	1	N	O
and	CC	and	and	and	N	O
2	CD	2	2	2	N	O
)	)	)	)	)	N	O
[	NN	[	[	[	N	O
see	VBP	see	see	see	N	O
Clinical	JJ	clinical	clinical	clinic	N	O
Studies	NNP	studies	study	studi	N	O
(	(	(	(	(	N	O
14	CD	14	14	14	N	O
)]	NN	)]	)]	)]	N	O
.	.	.	.	.	N	O

Only	RB	only	only	onli	N	O
Study	NNP	study	study	studi	N	O
1	CD	1	1	1	N	O
included	VBD	included	included	includ	N	O
a	DT	a	a	a	N	O
placebo	NN	placebo	placebo	placebo	N	O
group	NN	group	group	group	N	O
,	,	,	,	,	N	O
allowing	VBG	allowing	allowing	allow	N	O
comparison	NN	comparison	comparison	comparison	N	O
of	IN	of	of	of	N	O
adverse	JJ	adverse	adverse	advers	N	O
reaction	NN	reaction	reaction	reaction	N	O
rates	NNS	rates	rate	rate	N	O
on	IN	on	on	on	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
at	IN	at	at	at	N	O
several	JJ	several	several	sever	N	O
doses	NNS	doses	dos	dose	N	O
to	TO	to	to	to	N	O
placebo	VB	placebo	placebo	placebo	N	O
.	.	.	.	.	N	O

Adverse	JJ	adverse	adverse	advers	N	O
Reactions	NNP	reactions	reaction	reaction	N	O
Leading	NNP	leading	leading	lead	N	O
to	TO	to	to	to	N	O
Discontinuation	NNP	discontinuation	discontinuation	discontinu	N	O
in	IN	in	in	in	N	O
an	DT	an	an	an	N	O
LGS	NNP	lgs	lgs	lg	N	O
Placebo	NNP	placebo	placebo	placebo	N	O
Controlled	NNP	controlled	controlled	control	N	O
Clinical	NNP	clinical	clinical	clinic	N	O
Trial	NNP	trial	trial	trial	N	O
(	(	(	(	(	N	O
Study	NNP	study	study	studi	N	O
1	CD	1	1	1	N	O
)	)	)	)	)	N	O
The	DT	the	the	the	N	O
adverse	JJ	adverse	adverse	advers	N	O
reactions	NNS	reactions	reaction	reaction	N	O
associated	VBN	associated	associated	associ	N	O
with	IN	with	with	with	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
treatment	NN	treatment	treatment	treatment	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
in	IN	in	in	in	N	O
1%	CD	1%	1%	1%	N	O
of	IN	of	of	of	N	O
patients	NNS	patients	patient	patient	N	O
in	IN	in	in	in	N	O
decreasing	VBG	decreasing	decreasing	decreas	N	O
order	NN	order	order	order	N	O
of	IN	of	of	of	N	O
frequency	NN	frequency	frequency	frequenc	N	O
included	VBD	included	included	includ	N	O
lethargy	NN	lethargy	lethargy	lethargi	Y	B-AdverseReaction
,	,	,	,	,	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
,	,	,	,	,	N	O
ataxia	NN	ataxia	ataxia	ataxia	Y	B-AdverseReaction
,	,	,	,	,	N	O
aggression	NN	aggression	aggression	aggress	Y	B-AdverseReaction
,	,	,	,	,	N	O
fatigue	NN	fatigue	fatigue	fatigu	Y	B-AdverseReaction
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
insomnia	NN	insomnia	insomnia	insomnia	Y	B-AdverseReaction
.	.	.	.	.	N	O

Most	JJS	most	most	most	N	O
Common	JJ	common	common	common	N	O
Adverse	JJ	adverse	adverse	advers	N	O
Reactions	NNP	reactions	reaction	reaction	N	O
in	IN	in	in	in	N	O
an	DT	an	an	an	N	O
LGS	NNP	lgs	lgs	lg	N	O
Placebo	NNP	placebo	placebo	placebo	N	O
Controlled	NNP	controlled	controlled	control	N	O
Clinical	NNP	clinical	clinical	clinic	N	O
Trial	NNP	trial	trial	trial	N	O
(	(	(	(	(	N	O
Study	NNP	study	study	studi	N	O
1	CD	1	1	1	N	O
)	)	)	)	)	N	O
Table	NN	table	table	tabl	N	O
3	CD	3	3	3	N	O
lists	VBZ	lists	list	list	N	O
the	DT	the	the	the	N	O
adverse	JJ	adverse	adverse	advers	N	O
reactions	NNS	reactions	reaction	reaction	N	O
that	WDT	that	that	that	N	O
occurred	VBD	occurred	occurred	occur	N	O
in	IN	in	in	in	N	O
5%	CD	5%	5%	5%	N	O
of	IN	of	of	of	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
treated	VBD	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
(	(	(	(	(	N	O
at	IN	at	at	at	N	O
any	DT	any	any	ani	N	O
dose	NN	dose	dose	dose	N	O
)	)	)	)	)	N	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
at	IN	at	at	at	N	O
a	DT	a	a	a	N	O
rate	NN	rate	rate	rate	N	O
greater	JJR	greater	greater	greater	N	O
than	IN	than	than	than	N	O
placebo	NN	placebo	placebo	placebo	N	O
treated	VBN	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
,	,	,	,	,	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
randomized	NN	randomized	randomized	random	N	O
,	,	,	,	,	N	O
double	JJ	double	double	doubl	N	O
-	:	-	-	-	N	O
blind	NN	blind	blind	blind	Y	O
,	,	,	,	,	N	O
placebo	SYM	placebo	placebo	placebo	N	O
-	:	-	-	-	N	O
controlled	VBN	controlled	controlled	control	N	O
,	,	,	,	,	N	O
parallel	JJ	parallel	parallel	parallel	N	O
group	NN	group	group	group	N	O
clinical	JJ	clinical	clinical	clinic	N	O
study	NN	study	study	studi	N	O
of	IN	of	of	of	N	O
adjunctive	JJ	adjunctive	adjunctive	adjunct	N	O
AED	NNP	aed	aed	a	N	O
therapy	NN	therapy	therapy	therapi	N	O
for	IN	for	for	for	N	O
15	CD	15	15	15	N	O
weeks	NNS	weeks	week	week	N	O
(	(	(	(	(	N	O
Study	NNP	study	study	studi	N	O
1	CD	1	1	1	N	O
)	)	)	)	)	N	O
.	.	.	.	.	N	O

Table	JJ	table	table	tabl	N	O
3	CD	3	3	3	N	O
.	.	.	.	.	N	O

Adverse	JJ	adverse	adverse	advers	N	O
Reactions	NNP	reactions	reaction	reaction	N	O
Reported	VBD	reported	reported	report	N	O
for	IN	for	for	for	N	O
5%	CD	5%	5%	5%	N	O
of	IN	of	of	of	N	O
Patients	NNS	patients	patient	patient	N	O
and	CC	and	and	and	N	O
More	JJR	more	more	more	N	O
Frequently	RB	frequently	frequently	frequent	N	O
than	IN	than	than	than	N	O
Placebo	NNP	placebo	placebo	placebo	N	O
in	IN	in	in	in	N	O
Any	NNP	any	any	ani	N	O
Treatment	NNP	treatment	treatment	treatment	N	O
Group	NNP	group	group	group	N	O

a	DT	a	a	a	N	O
Maximum	JJ	maximum	maximum	maximum	N	O
daily	JJ	daily	daily	daili	N	O
dose	NN	dose	dose	dose	N	O
of	IN	of	of	of	N	O
5	CD	5	5	5	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O
;	:	;	;	;	N	O
10	CD	10	10	10	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O
b	JJ	b	b	b	N	O
Maximum	NNP	maximum	maximum	maximum	N	O
daily	JJ	daily	daily	daili	N	O
dose	NN	dose	dose	dose	N	O
of	IN	of	of	of	N	O
10	CD	10	10	10	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O
;	:	;	;	;	N	O
20	CD	20	20	20	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O
c	JJ	c	c	c	N	O
Maximum	NNP	maximum	maximum	maximum	N	O
daily	JJ	daily	daily	daili	N	O
dose	NN	dose	dose	dose	N	O
of	IN	of	of	of	N	O
20	CD	20	20	20	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O
;	:	;	;	;	N	O
40	CD	40	40	40	N	O
mg	NN	mg	mg	mg	N	O
for	IN	for	for	for	N	O
30	CD	30	30	30	N	O
kg	NNS	kg	kg	kg	N	O
body	NN	body	body	bodi	N	O
weight	VBD	weight	weight	weight	Y	O

Placebo	NN	placebo	placebo	placebo	N	O

N	NNP	n	n	n	N	O
59	CD	59	59	59	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
Dose	NNP	dose	dose	dose	N	O
Level	NNP	level	level	level	N	O
All	NNP	all	all	all	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
N	NNP	n	n	n	N	O
179	CD	179	179	179	N	O

Low	NNP	low	low	low	N	O
a	DT	a	a	a	N	O
N	NNP	n	n	n	N	O
58	CD	58	58	58	N	O
Medium	NNP	medium	medium	medium	N	O
b	NN	b	b	b	N	O
N	NNP	n	n	n	N	O
62	CD	62	62	62	N	O
High	NNP	high	high	high	N	O
c	NN	c	c	c	N	O
N	NNP	n	n	n	N	O
59	CD	59	59	59	N	O

Gastrointestinal	JJ	gastrointestinal	gastrointestinal	gastrointestin	N	O
Disorders	NNS	disorders	disorder	disord	N	O

Vomiting	VBG	vomiting	vomiting	vomit	Y	B-AdverseReaction
5	CD	5	5	5	N	O
9	CD	9	9	9	N	O
5	CD	5	5	5	N	O
7	CD	7	7	7	N	O
7	CD	7	7	7	N	O

Constipation	NN	constipation	constipation	constip	Y	B-AdverseReaction
0	CD	0	0	0	N	O
2	CD	2	2	2	N	O
2	CD	2	2	2	N	O
10	CD	10	10	10	N	O
5	CD	5	5	5	N	O

Dysphagia	NNP	dysphagia	dysphagia	dysphagia	Y	B-AdverseReaction
0	CD	0	0	0	N	O
0	CD	0	0	0	N	O
0	CD	0	0	0	N	O
5	CD	5	5	5	N	O
2	CD	2	2	2	N	O

General	NNP	general	general	gener	N	O
Disorders	NNP	disorders	disorder	disord	N	O
and	CC	and	and	and	N	O
Administration	NNP	administration	administration	administr	N	O
Site	NNP	site	site	site	N	O
Conditions	NNS	conditions	condition	condit	N	O

Pyrexia	NNP	pyrexia	pyrexia	pyrexia	Y	B-AdverseReaction
3	CD	3	3	3	N	O
17	CD	17	17	17	N	O
10	CD	10	10	10	N	O
12	CD	12	12	12	N	O
13	CD	13	13	13	N	O

Irritability	NNP	irritability	irritability	irrit	Y	B-AdverseReaction
5	CD	5	5	5	N	O
3	CD	3	3	3	N	O
11	CD	11	11	11	N	O
5	CD	5	5	5	N	O
7	CD	7	7	7	N	O

Fatigue	NNP	fatigue	fatigue	fatigu	Y	B-AdverseReaction
2	CD	2	2	2	N	O
5	CD	5	5	5	N	O
5	CD	5	5	5	N	O
3	CD	3	3	3	N	O
5	CD	5	5	5	N	O

Infections	NNS	infections	infection	infect	N	O
and	CC	and	and	and	N	O
Infestations	NNS	infestations	infestation	infest	N	O

Upper	NNP	upper	upper	upper	N	B-AdverseReaction
respiratory	NN	respiratory	respiratory	respiratori	N	I-AdverseReaction
tract	NN	tract	tract	tract	N	I-AdverseReaction
infection	NN	infection	infection	infect	Y	I-AdverseReaction
10	CD	10	10	10	N	O
10	CD	10	10	10	N	O
13	CD	13	13	13	N	O
14	CD	14	14	14	N	O
12	CD	12	12	12	N	O

Pneumonia	NNP	pneumonia	pneumonia	pneumonia	Y	B-AdverseReaction
2	CD	2	2	2	N	O
3	CD	3	3	3	N	O
3	CD	3	3	3	N	O
7	CD	7	7	7	N	O
4	CD	4	4	4	N	O

Urinary	JJ	urinary	urinary	urinari	N	B-AdverseReaction
tract	NN	tract	tract	tract	N	I-AdverseReaction
infection	NN	infection	infection	infect	Y	I-AdverseReaction
0	CD	0	0	0	N	O
2	CD	2	2	2	N	O
5	CD	5	5	5	N	O
5	CD	5	5	5	N	O
4	CD	4	4	4	N	O

Bronchitis	NNP	bronchitis	bronchitis	bronchiti	Y	B-AdverseReaction
0	CD	0	0	0	N	O
2	CD	2	2	2	N	O
0	CD	0	0	0	N	O
5	CD	5	5	5	N	O
2	CD	2	2	2	N	O

Metabolism	NN	metabolism	metabolism	metabol	N	O
and	CC	and	and	and	N	O
Nutrition	NN	nutrition	nutrition	nutrit	N	O
Disorders	NNS	disorders	disorder	disord	N	O

Decreased	VBN	decreased	decreased	decreas	N	B-AdverseReaction
appetite	RB	appetite	appetite	appetit	N	I-AdverseReaction
3	CD	3	3	3	N	O
3	CD	3	3	3	N	O
0	CD	0	0	0	N	O
7	CD	7	7	7	N	O
3	CD	3	3	3	N	O

Increased	VBN	increased	increased	increas	N	B-AdverseReaction
appetite	RB	appetite	appetite	appetit	N	I-AdverseReaction
0	CD	0	0	0	N	O
2	CD	2	2	2	N	O
3	CD	3	3	3	N	O
5	CD	5	5	5	N	O
3	CD	3	3	3	N	O

Nervous	JJ	nervous	nervous	nervou	Y	O
System	NNP	system	system	system	N	O
Disorders	NNP	disorders	disorder	disord	N	O

Somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
or	CC	or	or	or	N	O
Sedation	NNP	sedation	sedation	sedat	Y	B-AdverseReaction
15	CD	15	15	15	N	O
17	CD	17	17	17	N	O
27	CD	27	27	27	N	O
32	CD	32	32	32	N	O
26	CD	26	26	26	N	O

Somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
12	CD	12	12	12	N	O
16	CD	16	16	16	N	O
24	CD	24	24	24	N	O
25	CD	25	25	25	N	O
22	CD	22	22	22	N	O

Sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
3	CD	3	3	3	N	O
2	CD	2	2	2	N	O
3	CD	3	3	3	N	O
9	CD	9	9	9	N	O
5	CD	5	5	5	N	O

Lethargy	NNP	lethargy	lethargy	lethargi	Y	B-AdverseReaction
5	CD	5	5	5	N	O
10	CD	10	10	10	N	O
5	CD	5	5	5	N	O
15	CD	15	15	15	N	O
10	CD	10	10	10	N	O

Drooling	VBG	drooling	drooling	drool	Y	B-AdverseReaction
3	CD	3	3	3	N	O
0	CD	0	0	0	N	O
13	CD	13	13	13	N	O
14	CD	14	14	14	N	O
9	CD	9	9	9	N	O

Ataxia	NNP	ataxia	ataxia	ataxia	Y	B-AdverseReaction
3	CD	3	3	3	N	O
3	CD	3	3	3	N	O
2	CD	2	2	2	N	O
10	CD	10	10	10	N	O
5	CD	5	5	5	N	O

Psychomotor	NNP	psychomotor	psychomotor	psychomotor	N	B-AdverseReaction
hyperactivity	NN	hyperactivity	hyperactivity	hyperact	Y	I-AdverseReaction
3	CD	3	3	3	N	O
3	CD	3	3	3	N	O
3	CD	3	3	3	N	O
5	CD	5	5	5	N	O
4	CD	4	4	4	N	O

Dysarthria	NNP	dysarthria	dysarthria	dysarthria	Y	B-AdverseReaction
0	CD	0	0	0	N	O
2	CD	2	2	2	N	O
2	CD	2	2	2	N	O
5	CD	5	5	5	N	O
3	CD	3	3	3	N	O

Psychiatric	JJ	psychiatric	psychiatric	psychiatr	N	O
Disorders	NNS	disorders	disorder	disord	N	O

Aggression	NNP	aggression	aggression	aggress	Y	B-AdverseReaction
5	CD	5	5	5	N	O
3	CD	3	3	3	N	O
8	CD	8	8	8	N	O
14	CD	14	14	14	N	O
8	CD	8	8	8	N	O

Insomnia	NNP	insomnia	insomnia	insomnia	Y	B-AdverseReaction
2	CD	2	2	2	N	O
2	CD	2	2	2	N	O
5	CD	5	5	5	N	O
7	CD	7	7	7	N	O
5	CD	5	5	5	N	O

Respiratory	NN	respiratory	respiratory	respiratori	N	O
Disorders	NNS	disorders	disorder	disord	N	O

Cough	NNP	cough	cough	cough	Y	B-AdverseReaction
0	CD	0	0	0	N	O
3	CD	3	3	3	N	O
5	CD	5	5	5	N	O
7	CD	7	7	7	N	O
5	CD	5	5	5	N	O

6.2	CD	6.2	6.2	6.2	N	O
Post	NNP	post	post	post	N	O
Marketing	NNP	marketing	marketing	market	N	O
Experience	NN	experience	experience	experi	N	O

These	DT	these	these	these	N	O
reactions	NNS	reactions	reaction	reaction	N	O
are	VBP	are	are	are	N	O
reported	VBN	reported	reported	report	N	O
voluntarily	RB	voluntarily	voluntarily	voluntarili	N	O
from	IN	from	from	from	N	O
a	DT	a	a	a	N	O
population	NN	population	population	popul	N	O
of	IN	of	of	of	N	O
uncertain	JJ	uncertain	uncertain	uncertain	N	O
size	NN	size	size	size	N	O
;	:	;	;	;	N	O
therefore	RB	therefore	therefore	therefor	N	O
,	,	,	,	,	N	O
it	PRP	it	it	it	N	O
is	VBZ	is	is	is	N	O
not	RB	not	not	not	N	O
possible	JJ	possible	possible	possibl	N	O
to	TO	to	to	to	N	O
estimate	VB	estimate	estimate	estim	N	O
their	PRP$	their	their	their	N	O
frequency	NN	frequency	frequency	frequenc	N	O
or	CC	or	or	or	N	O
establish	VB	establish	establish	establish	N	O
a	DT	a	a	a	N	O
causal	NN	causal	causal	causal	N	O
relationship	NN	relationship	relationship	relationship	N	O
to	TO	to	to	to	N	O
drug	NN	drug	drug	drug	N	O
exposure	NN	exposure	exposure	exposur	N	O
.	.	.	.	.	N	O

Adverse	JJ	adverse	adverse	advers	N	O
reactions	NNS	reactions	reaction	reaction	N	O
are	VBP	are	are	are	N	O
categorized	VBN	categorized	categorized	categor	N	O
by	IN	by	by	by	N	O
system	NN	system	system	system	N	O
organ	JJ	organ	organ	organ	N	O
class	NN	class	class	class	N	O
.	.	.	.	.	N	O

Blood	NN	blood	blood	blood	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Anemia	NNP	anemia	anemia	anemia	Y	B-AdverseReaction
,	,	,	,	,	N	O
eosinophilia	NN	eosinophilia	eosinophilia	eosinophilia	Y	B-AdverseReaction
,	,	,	,	,	N	O
leukopenia	NN	leukopenia	leukopenia	leukopenia	Y	B-AdverseReaction
,	,	,	,	,	N	O
thrombocytopenia	NN	thrombocytopenia	thrombocytopenia	thrombocytopenia	Y	B-AdverseReaction
Eye	NNP	eye	eye	eye	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Diplopia	NNP	diplopia	diplopia	diplopia	Y	B-AdverseReaction
,	,	,	,	,	N	O
vision	NN	vision	vision	vision	N	B-AdverseReaction
blurred	VBD	blurred	blurred	blur	N	I-AdverseReaction
Gastrointestinal	NNP	gastrointestinal	gastrointestinal	gastrointestin	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Abdominal	NNP	abdominal	abdominal	abdomin	N	B-AdverseReaction
distention	NN	distention	distention	distent	Y	I-AdverseReaction
General	NNP	general	general	gener	N	O
Disorders	NNP	disorders	disorder	disord	N	O
and	CC	and	and	and	N	O
Administration	NNP	administration	administration	administr	N	O
Site	NNP	site	site	site	N	O
Conditions	NNS	conditions	condition	condit	N	O
:	:	:	:	:	N	O
Hypothermia	NNP	hypothermia	hypothermia	hypothermia	Y	B-AdverseReaction
Investigations	NNS	investigations	investigation	investig	N	O
:	:	:	:	:	N	O
Hepatic	JJ	hepatic	hepatic	hepat	N	B-AdverseReaction
enzyme	NN	enzyme	enzyme	enzym	N	I-AdverseReaction
increased	VBD	increased	increased	increas	N	I-AdverseReaction
Musculoskeletal	NNP	musculoskeletal	musculoskeletal	musculoskelet	N	O
:	:	:	:	:	N	O
Muscle	NN	muscle	muscle	muscl	N	B-AdverseReaction
spasms	NNS	spasms	spasm	spasm	Y	I-AdverseReaction
Psychiatric	JJ	psychiatric	psychiatric	psychiatr	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Agitation	NN	agitation	agitation	agit	Y	B-AdverseReaction
,	,	,	,	,	N	O
anxiety	NN	anxiety	anxiety	anxieti	Y	B-AdverseReaction
,	,	,	,	,	N	O
apathy	JJ	apathy	apathy	apathi	Y	B-AdverseReaction
,	,	,	,	,	N	O
confusional	JJ	confusional	confusional	confusion	N	B-AdverseReaction
state	NN	state	state	state	N	I-AdverseReaction
,	,	,	,	,	N	O
depression	NN	depression	depression	depress	Y	B-AdverseReaction
,	,	,	,	,	N	O
delirium	NN	delirium	delirium	delirium	Y	B-AdverseReaction
,	,	,	,	,	N	O
delusion	NN	delusion	delusion	delus	Y	B-AdverseReaction
,	,	,	,	,	N	O
hallucination	NN	hallucination	hallucination	hallucin	Y	B-AdverseReaction
Renal	NNP	renal	renal	renal	N	O
and	CC	and	and	and	N	O
Urinary	JJ	urinary	urinary	urinari	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Urinary	JJ	urinary	urinary	urinari	N	B-AdverseReaction
retention	NN	retention	retention	retent	N	I-AdverseReaction
Respiratory	NNP	respiratory	respiratory	respiratori	N	O
Disorders	NNS	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Aspiration	NN	aspiration	aspiration	aspir	Y	B-AdverseReaction
,	,	,	,	,	N	O
respiratory	JJ	respiratory	respiratory	respiratori	N	B-AdverseReaction
depression	NN	depression	depression	depress	Y	I-AdverseReaction
Skin	NNP	skin	skin	skin	N	O
and	CC	and	and	and	N	O
Subcutaneous	NNP	subcutaneous	subcutaneous	subcutan	N	O
Tissue	NNP	tissue	tissue	tissu	N	O
Disorders	NNP	disorders	disorder	disord	N	O
:	:	:	:	:	N	O
Rash	NNP	rash	rash	rash	Y	B-AdverseReaction
,	,	,	,	,	N	O
urticaria	NN	urticaria	urticaria	urticaria	Y	B-AdverseReaction
,	,	,	,	,	N	O
angioedema	NN	angioedema	angioedema	angioedema	Y	B-AdverseReaction
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
facial	JJ	facial	facial	facial	N	B-AdverseReaction
and	CC	and	and	and	N	O
lip	JJ	lip	lip	lip	N	B-AdverseReaction
edema	NN	edema	edema	edema	Y	I-AdverseReaction
5	CD	5	5	5	N	O
WARNINGS	NNP	warnings	warning	warn	N	O
AND	NNP	and	and	and	N	O
PRECAUTIONS	NNP	precautions	precaution	precaut	N	O

EXCERPT	NN	excerpt	excerpt	excerpt	N	O
:	:	:	:	:	N	O
Somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
or	CC	or	or	or	N	O
Sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
:	:	:	:	:	N	O
Monitor	NN	monitor	monitor	monitor	N	O
for	IN	for	for	for	N	O
central	JJ	central	central	central	N	O
nervous	JJ	nervous	nervous	nervou	Y	O
system	NN	system	system	system	N	O
(	(	(	(	(	N	O
CNS	NNP	cns	cns	cn	N	O
)	)	)	)	)	N	O
depression	NN	depression	depression	depress	Y	O
.	.	.	.	.	N	O

Risk	NN	risk	risk	risk	N	O
may	MD	may	may	may	N	O
be	VB	be	be	be	N	O
increased	VBN	increased	increased	increas	N	O
with	IN	with	with	with	N	O
concomitant	JJ	concomitant	concomitant	concomit	N	O
use	NN	use	use	use	N	O
of	IN	of	of	of	N	O
other	JJ	other	other	other	N	O
CNS	NNP	cns	cns	cn	N	O
depressants	NNS	depressants	depressant	depress	N	O
.	.	.	.	.	N	O

(	(	(	(	(	N	O
5.1	CD	5.1	5.1	5.1	N	O
,	,	,	,	,	N	O
5.2	CD	5.2	5.2	5.2	N	O
)	)	)	)	)	N	O

Withdrawal	NN	withdrawal	withdrawal	withdraw	N	O
:	:	:	:	:	N	O
Symptoms	NNS	symptoms	symptom	symptom	N	O
may	MD	may	may	may	N	O
occur	VB	occur	occur	occur	N	O
with	IN	with	with	with	N	O
rapid	JJ	rapid	rapid	rapid	N	O
dose	JJ	dose	dose	dose	N	O
reduction	NN	reduction	reduction	reduct	N	O
or	CC	or	or	or	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
.	.	.	.	.	N	O

Discontinue	NNP	discontinue	discontinue	discontinu	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
gradually	RB	gradually	gradually	gradual	N	O
.	.	.	.	.	N	O

(	(	(	(	(	N	O
5.3	CD	5.3	5.3	5.3	N	O
)	)	)	)	)	N	O

Serious	JJ	serious	serious	seriou	N	B-Severity
Dermatological	NNP	dermatological	dermatological	dermatolog	N	B-AdverseReaction
Reactions	NNP	reactions	reaction	reaction	N	I-AdverseReaction
(	(	(	(	(	N	O
including	VBG	including	including	includ	N	O
Stevens	NNP	stevens	stevens	steven	N	B-AdverseReaction
-	:	-	-	-	N	I-AdverseReaction
Johnson	NNP	johnson	johnson	johnson	N	I-AdverseReaction
syndrome	NN	syndrome	syndrome	syndrom	N	I-AdverseReaction
and	CC	and	and	and	N	O
toxic	NN	toxic	toxic	toxic	N	B-AdverseReaction
epidermal	JJ	epidermal	epidermal	epiderm	N	I-AdverseReaction
necrolysis	NN	necrolysis	necrolysis	necrolysi	N	I-AdverseReaction
)	)	)	)	)	N	O
:	:	:	:	:	N	O
Discontinue	NN	discontinue	discontinue	discontinu	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
at	IN	at	at	at	N	O
first	JJ	first	first	first	N	O
sign	NN	sign	sign	sign	N	O
of	IN	of	of	of	N	O
rash	NN	rash	rash	rash	Y	O
unless	IN	unless	unless	unless	N	O
the	DT	the	the	the	N	O
rash	NN	rash	rash	rash	Y	O
is	VBZ	is	is	is	N	O
clearly	RB	clearly	clearly	clearli	N	O
not	RB	not	not	not	N	O
drug	NN	drug	drug	drug	N	O
-	:	-	-	-	N	O
related	VBN	related	related	relat	N	O
.	.	.	.	.	N	O

(	(	(	(	(	N	O
5.4	CD	5.4	5.4	5.4	N	O
)	)	)	)	)	N	O

Physical	JJ	physical	physical	physic	N	B-AdverseReaction
and	CC	and	and	and	N	O
Psychological	JJ	psychological	psychological	psycholog	N	B-AdverseReaction
Dependence	NN	dependence	dependence	depend	Y	I-AdverseReaction
:	:	:	:	:	N	O
Monitor	NN	monitor	monitor	monitor	N	O
patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
a	DT	a	a	a	N	O
history	NN	history	history	histori	N	O
of	IN	of	of	of	N	O
substance	NN	substance	substance	substanc	N	O
abuse	NN	abuse	abuse	abus	N	O
for	IN	for	for	for	N	O
signs	NNS	signs	sign	sign	N	O
of	IN	of	of	of	N	O
habituation	NN	habituation	habituation	habitu	Y	O
and	CC	and	and	and	N	O
dependence	NN	dependence	dependence	depend	Y	O
(	(	(	(	(	N	O
5.5	CD	5.5	5.5	5.5	N	O
,	,	,	,	,	N	O
9	CD	9	9	9	N	O
)	)	)	)	)	N	O

Suicidal	NNP	suicidal	suicidal	suicid	N	B-AdverseReaction
Behavior	NNP	behavior	behavior	behavior	N	I-AdverseReaction
and	CC	and	and	and	N	O
Ideation	NNP	ideation	ideation	ideat	N	I-AdverseReaction
:	:	:	:	:	N	O
Monitor	NN	monitor	monitor	monitor	N	O
for	IN	for	for	for	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
or	CC	or	or	or	N	O
behaviors	NNS	behaviors	behavior	behavior	N	O
(	(	(	(	(	N	O
5.6	CD	5.6	5.6	5.6	N	O
)	)	)	)	)	N	O

5.1	CD	5.1	5.1	5.1	N	O

Somnolence	NN	somnolence	somnolence	somnol	Y	O

or	CC	or	or	or	N	O
Sedation	NN	sedation	sedation	sedat	Y	O

ONFI	NNP	onfi	onfi	onfi	N	O
causes	VBZ	causes	cause	caus	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
and	CC	and	and	and	N	O
sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
.	.	.	.	.	N	O

In	IN	in	in	in	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
,	,	,	,	,	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
or	CC	or	or	or	N	O
sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
was	VBD	was	wa	wa	N	O
reported	VBN	reported	reported	report	N	O
at	IN	at	at	at	N	O
all	DT	all	all	all	N	O
effective	JJ	effective	effective	effect	N	O
doses	NNS	doses	dos	dose	N	O
and	CC	and	and	and	N	O
was	VBD	was	wa	wa	N	O
dose	JJ	dose	dose	dose	N	O
-	:	-	-	-	N	O
related	VBN	related	related	relat	N	O
.	.	.	.	.	N	O

In	IN	in	in	in	N	O
general	JJ	general	general	gener	N	O
,	,	,	,	,	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	B-AdverseReaction
and	CC	and	and	and	N	O
sedation	NN	sedation	sedation	sedat	Y	B-AdverseReaction
begin	NN	begin	begin	begin	N	O
within	IN	within	within	within	N	O
the	DT	the	the	the	N	O
first	JJ	first	first	first	N	O
month	NN	month	month	month	N	O
of	IN	of	of	of	N	O
treatment	NN	treatment	treatment	treatment	N	O
and	CC	and	and	and	N	O
may	MD	may	may	may	N	O
diminish	VB	diminish	diminish	diminish	N	O
with	IN	with	with	with	N	O
continued	JJ	continued	continued	continu	N	O
treatment	NN	treatment	treatment	treatment	N	O
.	.	.	.	.	N	O

Prescribers	NNS	prescribers	prescribers	prescrib	N	O
should	MD	should	should	should	N	O
monitor	VB	monitor	monitor	monitor	N	O
patients	NNS	patients	patient	patient	N	O
for	IN	for	for	for	N	O
somnolence	NN	somnolence	somnolence	somnol	Y	O
and	CC	and	and	and	N	O
sedation	NN	sedation	sedation	sedat	Y	O
,	,	,	,	,	N	O
particularly	RB	particularly	particularly	particularli	N	O
with	IN	with	with	with	N	O
concomitant	JJ	concomitant	concomitant	concomit	N	O
use	NN	use	use	use	N	O
of	IN	of	of	of	N	O
other	JJ	other	other	other	N	O
central	JJ	central	central	central	N	O
nervous	JJ	nervous	nervous	nervou	Y	O
system	NN	system	system	system	N	O
depressants	NNS	depressants	depressant	depress	N	O
.	.	.	.	.	N	O

Prescribers	NNS	prescribers	prescribers	prescrib	N	O
should	MD	should	should	should	N	O
caution	VB	caution	caution	caution	N	O
patients	NNS	patients	patient	patient	N	O
against	IN	against	against	against	N	O
engaging	VBG	engaging	engaging	engag	N	O
in	IN	in	in	in	N	O
hazardous	JJ	hazardous	hazardous	hazard	N	O
activities	NNS	activities	activity	activ	N	O
requiring	VBG	requiring	requiring	requir	N	O
mental	JJ	mental	mental	mental	N	O
alertness	NN	alertness	alertness	alert	N	O
,	,	,	,	,	N	O
such	JJ	such	such	such	N	O
as	IN	as	a	as	N	O
operating	VBG	operating	operating	oper	N	O
dangerous	JJ	dangerous	dangerous	danger	N	O
machinery	NN	machinery	machinery	machineri	N	O
or	CC	or	or	or	N	O
motor	NN	motor	motor	motor	N	O
vehicles	NNS	vehicles	vehicle	vehicl	N	O
,	,	,	,	,	N	O
until	IN	until	until	until	N	O
the	DT	the	the	the	N	O
effect	NN	effect	effect	effect	N	O
of	IN	of	of	of	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
is	VBZ	is	is	is	N	O
known	VBN	known	known	known	N	O
.	.	.	.	.	N	O

5.2	CD	5.2	5.2	5.2	N	O
Potentiation	NN	potentiation	potentiation	potenti	N	O
of	IN	of	of	of	N	O
Sedation	NN	sedation	sedation	sedat	Y	O
from	IN	from	from	from	N	O
Concomitant	NNP	concomitant	concomitant	concomit	N	O
Use	NNP	use	use	use	N	O
with	IN	with	with	with	N	O
Central	NNP	central	central	central	N	O
Nervous	NNP	nervous	nervous	nervou	Y	O
System	NNP	system	system	system	N	O
Depressants	NNP	depressants	depressant	depress	N	O

Since	IN	since	since	sinc	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
has	VBZ	has	ha	ha	N	O
a	DT	a	a	a	N	O
central	JJ	central	central	central	N	O
nervous	JJ	nervous	nervous	nervou	Y	O
system	NN	system	system	system	N	O
(	(	(	(	(	N	O
CNS	NNP	cns	cns	cn	N	O
)	)	)	)	)	N	O
depressant	NN	depressant	depressant	depress	N	O
effect	NN	effect	effect	effect	N	O
,	,	,	,	,	N	O
patients	NNS	patients	patient	patient	N	O
or	CC	or	or	or	N	O
their	PRP$	their	their	their	N	O
caregivers	NNS	caregivers	caregiver	caregiv	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
cautioned	VBN	cautioned	cautioned	caution	N	O
against	IN	against	against	against	N	O
simultaneous	JJ	simultaneous	simultaneous	simultan	N	O
use	NN	use	use	use	N	O
with	IN	with	with	with	N	O
other	JJ	other	other	other	N	O
CNS	NNP	cns	cns	cn	N	O
depressant	NN	depressant	depressant	depress	N	O
drugs	NNS	drugs	drug	drug	N	O
or	CC	or	or	or	N	O
alcohol	NN	alcohol	alcohol	alcohol	N	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
cautioned	VBD	cautioned	cautioned	caution	N	O
that	IN	that	that	that	N	O
the	DT	the	the	the	N	O
effects	NNS	effects	effect	effect	N	O
of	IN	of	of	of	N	O
other	JJ	other	other	other	N	O
CNS	NNP	cns	cns	cn	N	O
depressant	NN	depressant	depressant	depress	N	O
drugs	NNS	drugs	drug	drug	N	O
or	CC	or	or	or	N	O
alcohol	NN	alcohol	alcohol	alcohol	N	O
may	MD	may	may	may	N	O
be	VB	be	be	be	N	O
potentiated	VBN	potentiated	potentiated	potenti	N	O
.	.	.	.	.	N	O

5.3	CD	5.3	5.3	5.3	N	O
Withdrawal	NNP	withdrawal	withdrawal	withdraw	N	O
Symptoms	NNP	symptoms	symptom	symptom	N	O

Abrupt	NNP	abrupt	abrupt	abrupt	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
of	IN	of	of	of	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
avoided	VBN	avoided	avoided	avoid	N	O
.	.	.	.	.	N	O

ONFI	NNP	onfi	onfi	onfi	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
tapered	VBN	tapered	tapered	taper	N	O
by	IN	by	by	by	N	O
decreasing	VBG	decreasing	decreasing	decreas	N	O
the	DT	the	the	the	N	O
dose	NN	dose	dose	dose	N	O
every	DT	every	every	everi	N	O
week	NN	week	week	week	N	O
by	IN	by	by	by	N	O
5	CD	5	5	5	N	O
-	:	-	-	-	N	O
10	CD	10	10	10	N	O
mg	JJ	mg	mg	mg	N	O
day	NN	day	day	day	N	O
until	IN	until	until	until	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Dosage	NNP	dosage	dosage	dosag	N	O
and	CC	and	and	and	N	O
Administration	NNP	administration	administration	administr	N	O
(	(	(	(	(	N	O
2.2	CD	2.2	2.2	2.2	N	O
)]	NN	)]	)]	)]	N	O
.	.	.	.	.	N	O

Withdrawal	NNP	withdrawal	withdrawal	withdraw	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
occurred	VBD	occurred	occurred	occur	N	O
following	VBG	following	following	follow	N	O
abrupt	JJ	abrupt	abrupt	abrupt	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
of	IN	of	of	of	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
;	:	;	;	;	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
withdrawal	NN	withdrawal	withdrawal	withdraw	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
is	VBZ	is	is	is	N	O
greater	JJR	greater	greater	greater	N	O
with	IN	with	with	with	N	O
higher	JJR	higher	higher	higher	N	O
doses	NNS	doses	dos	dose	N	O
.	.	.	.	.	N	O

As	IN	as	a	as	N	O
with	IN	with	with	with	N	O
all	DT	all	all	all	N	O
antiepileptic	JJ	antiepileptic	antiepileptic	antiepilept	N	O
drugs	NNS	drugs	drug	drug	N	O
,	,	,	,	,	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
withdrawn	VBN	withdrawn	withdrawn	withdrawn	Y	O
gradually	RB	gradually	gradually	gradual	N	O
to	TO	to	to	to	N	O
minimize	VB	minimize	minimize	minim	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
precipitating	VBG	precipitating	precipitating	precipit	N	O
seizures	NNS	seizures	seizure	seizur	Y	O
,	,	,	,	,	N	O
seizure	NN	seizure	seizure	seizur	Y	O
exacerbation	NN	exacerbation	exacerbation	exacerb	N	O
,	,	,	,	,	N	O
or	CC	or	or	or	N	O
status	NN	status	status	statu	N	O
epilepticus	NN	epilepticus	epilepticus	epilepticu	N	O
.	.	.	.	.	N	O

Withdrawal	NN	withdrawal	withdrawal	withdraw	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
(	(	(	(	(	N	O
e	NN	e	e	e	N	O
.	.	.	.	.	N	O
g	NN	g	g	g	N	O
.	.	.	.	.	N	O
,	,	,	,	,	N	O
convulsions	NNS	convulsions	convulsion	convuls	Y	O
,	,	,	,	,	N	O
psychosis	NN	psychosis	psychosis	psychosi	Y	O
,	,	,	,	,	N	O
hallucinations	NNS	hallucinations	hallucination	hallucin	Y	O
,	,	,	,	,	N	O
behavioral	JJ	behavioral	behavioral	behavior	N	O
disorder	NN	disorder	disorder	disord	N	O
,	,	,	,	,	N	O
tremor	NN	tremor	tremor	tremor	Y	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
anxiety	NN	anxiety	anxiety	anxieti	Y	O
)	)	)	)	)	N	O
have	VBP	have	have	have	N	O
been	VBN	been	been	been	N	O
reported	VBN	reported	reported	report	N	O
following	VBG	following	following	follow	N	O
abrupt	JJ	abrupt	abrupt	abrupt	N	O
discontinuance	NN	discontinuance	discontinuance	discontinu	N	O
of	IN	of	of	of	N	O
benzodiazepines	NNS	benzodiazepines	benzodiazepine	benzodiazepin	N	O
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
more	RBR	more	more	more	N	O
severe	JJ	severe	severe	sever	N	O
withdrawal	NN	withdrawal	withdrawal	withdraw	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
have	VBP	have	have	have	N	O
usually	RB	usually	usually	usual	N	O
been	VBN	been	been	been	N	O
limited	VBN	limited	limited	limit	N	O
to	TO	to	to	to	N	O
patients	NNS	patients	patient	patient	N	O
who	WP	who	who	who	N	O
received	VBD	received	received	receiv	N	O
excessive	JJ	excessive	excessive	excess	N	O
doses	NNS	doses	dos	dose	N	O
over	IN	over	over	over	N	O
an	DT	an	an	an	N	O
extended	JJ	extended	extended	extend	N	O
period	NN	period	period	period	N	O
of	IN	of	of	of	N	O
time	NN	time	time	time	N	O
,	,	,	,	,	N	O
followed	VBN	followed	followed	follow	N	O
by	IN	by	by	by	N	O
an	DT	an	an	an	N	O
abrupt	JJ	abrupt	abrupt	abrupt	N	O
discontinuation	NN	discontinuation	discontinuation	discontinu	N	O
.	.	.	.	.	N	O

Generally	RB	generally	generally	gener	N	O
milder	JJR	milder	milder	milder	N	O
withdrawal	NN	withdrawal	withdrawal	withdraw	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
(	(	(	(	(	N	O
e	NN	e	e	e	N	O
.	.	.	.	.	N	O
g	NN	g	g	g	N	O
.	.	.	.	.	N	O
,	,	,	,	,	N	O
dysphoria	NN	dysphoria	dysphoria	dysphoria	Y	O
,	,	,	,	,	N	O
anxiety	NN	anxiety	anxiety	anxieti	Y	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
insomnia	NN	insomnia	insomnia	insomnia	Y	O
)	)	)	)	)	N	O
have	VBP	have	have	have	N	O
been	VBN	been	been	been	N	O
reported	VBN	reported	reported	report	N	O
following	VBG	following	following	follow	N	O
abrupt	JJ	abrupt	abrupt	abrupt	N	O
discontinuance	NN	discontinuance	discontinuance	discontinu	N	O
of	IN	of	of	of	N	O
benzodiazepines	NNS	benzodiazepines	benzodiazepine	benzodiazepin	N	O
taken	VBN	taken	taken	taken	N	O
continuously	RB	continuously	continuously	continu	N	O
at	IN	at	at	at	N	O
therapeutic	JJ	therapeutic	therapeutic	therapeut	N	O
doses	NNS	doses	dos	dose	N	O
for	IN	for	for	for	N	O
several	JJ	several	several	sever	N	O
months	NNS	months	month	month	N	O
.	.	.	.	.	N	O

5.4	CD	5.4	5.4	5.4	N	O
Serious	JJ	serious	serious	seriou	N	O
Dermatological	NNP	dermatological	dermatological	dermatolog	N	O
Reactions	NNP	reactions	reaction	reaction	N	O

Serious	JJ	serious	serious	seriou	N	B-Severity
skin	NN	skin	skin	skin	N	B-AdverseReaction
reactions	NNS	reactions	reaction	reaction	N	I-AdverseReaction
,	,	,	,	,	N	O
including	VBG	including	including	includ	N	O
Stevens	NNP	stevens	stevens	steven	N	B-AdverseReaction
-	:	-	-	-	N	I-AdverseReaction
Johnson	NNP	johnson	johnson	johnson	N	I-AdverseReaction
syndrome	NN	syndrome	syndrome	syndrom	N	I-AdverseReaction
(	(	(	(	(	N	O
SJS	NNP	sjs	sjs	sj	N	B-AdverseReaction
)	)	)	)	)	N	O
and	CC	and	and	and	N	O
toxic	JJ	toxic	toxic	toxic	N	B-AdverseReaction
epidermal	JJ	epidermal	epidermal	epiderm	N	I-AdverseReaction
necrolysis	NN	necrolysis	necrolysis	necrolysi	N	I-AdverseReaction
(	(	(	(	(	N	O
TEN	NNP	ten	ten	ten	Y	B-AdverseReaction
)	)	)	)	)	N	O
,	,	,	,	,	N	O
have	VBP	have	have	have	N	O
been	VBN	been	been	been	N	O
reported	VBN	reported	reported	report	N	O
with	IN	with	with	with	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
in	IN	in	in	in	N	O
both	DT	both	both	both	N	O
children	NNS	children	child	children	N	O
and	CC	and	and	and	N	O
adults	NNS	adults	adult	adult	N	O
during	IN	during	during	dure	N	O
the	DT	the	the	the	N	O
post	NN	post	post	post	N	O
-	:	-	-	-	N	O
marketing	NN	marketing	marketing	market	N	O
period	NN	period	period	period	N	O
.	.	.	.	.	N	O

Patients	NNS	patients	patient	patient	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
closely	RB	closely	closely	close	N	O
monitored	VBN	monitored	monitored	monitor	N	O
for	IN	for	for	for	N	O
signs	NNS	signs	sign	sign	N	O
or	CC	or	or	or	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
of	IN	of	of	of	N	O
SJS	NNP	sjs	sjs	sj	N	O
TEN	NNP	ten	ten	ten	Y	O
,	,	,	,	,	N	O
especially	RB	especially	especially	especi	N	O
during	IN	during	during	dure	N	O
the	DT	the	the	the	N	O
first	JJ	first	first	first	N	O
8	CD	8	8	8	N	O
weeks	NNS	weeks	week	week	N	O
of	IN	of	of	of	N	O
treatment	NN	treatment	treatment	treatment	N	O
initiation	NN	initiation	initiation	initi	N	O
or	CC	or	or	or	N	O
when	WRB	when	when	when	N	O
re	JJ	re	re	re	N	O
-	:	-	-	-	N	O
introducing	NN	introducing	introducing	introduc	N	O
therapy	NN	therapy	therapy	therapi	N	O
.	.	.	.	.	N	O

ONFI	NNP	onfi	onfi	onfi	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
discontinued	VBN	discontinued	discontinued	discontinu	N	O
at	IN	at	at	at	N	O
the	DT	the	the	the	N	O
first	JJ	first	first	first	N	O
sign	NN	sign	sign	sign	N	O
of	IN	of	of	of	N	O
rash	NN	rash	rash	rash	Y	O
,	,	,	,	,	N	O
unless	IN	unless	unless	unless	N	O
the	DT	the	the	the	N	O
rash	NN	rash	rash	rash	Y	O
is	VBZ	is	is	is	N	O
clearly	RB	clearly	clearly	clearli	N	O
not	RB	not	not	not	N	O
drug	NN	drug	drug	drug	N	O
-	:	-	-	-	N	O
related	VBN	related	related	relat	N	O
.	.	.	.	.	N	O

If	IN	if	if	if	N	O
signs	NNS	signs	sign	sign	N	O
or	CC	or	or	or	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
suggest	VBP	suggest	suggest	suggest	N	O
SJS	NNP	sjs	sjs	sj	N	O
TEN	NNP	ten	ten	ten	Y	O
,	,	,	,	,	N	O
use	NN	use	use	use	N	O
of	IN	of	of	of	N	O
this	DT	this	this	thi	N	O
drug	NN	drug	drug	drug	N	O
should	MD	should	should	should	N	O
not	RB	not	not	not	N	O
be	VB	be	be	be	N	O
resumed	VBN	resumed	resumed	resum	N	O
and	CC	and	and	and	N	O
alternative	JJ	alternative	alternative	altern	N	O
therapy	NN	therapy	therapy	therapi	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
considered	VBN	considered	considered	consid	N	O
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Contraindications	NNP	contraindications	contraindication	contraind	N	O
(	(	(	(	(	N	O
4	CD	4	4	4	N	O
)]	NN	)]	)]	)]	N	O
.	.	.	.	.	N	O

5.5	CD	5.5	5.5	5.5	N	O
Physical	JJ	physical	physical	physic	N	O
and	CC	and	and	and	N	O
Psychological	JJ	psychological	psychological	psycholog	N	O
Dependence	NN	dependence	dependence	depend	Y	O

Patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
a	DT	a	a	a	N	O
history	NN	history	history	histori	N	O
of	IN	of	of	of	N	O
substance	NN	substance	substance	substanc	N	O
abuse	NN	abuse	abuse	abus	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
under	IN	under	under	under	N	O
careful	JJ	careful	careful	care	N	O
surveillance	NN	surveillance	surveillance	surveil	N	O
when	WRB	when	when	when	N	O
receiving	VBG	receiving	receiving	receiv	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
or	CC	or	or	or	N	O
other	JJ	other	other	other	N	O
psychotropic	NN	psychotropic	psychotropic	psychotrop	N	O
agents	NNS	agents	agent	agent	N	O
because	IN	because	because	becaus	N	O
of	IN	of	of	of	N	O
the	DT	the	the	the	N	O
predisposition	NN	predisposition	predisposition	predisposit	N	O
of	IN	of	of	of	N	O
such	JJ	such	such	such	N	O
patients	NNS	patients	patient	patient	N	O
to	TO	to	to	to	N	O
habituation	NN	habituation	habituation	habitu	Y	O
and	CC	and	and	and	N	O
dependence	NN	dependence	dependence	depend	Y	O
[	NNP	[	[	[	N	O
see	VBP	see	see	see	N	O
Drug	NNP	drug	drug	drug	N	O
Abuse	NNP	abuse	abuse	abus	N	O
and	CC	and	and	and	N	O
Dependence	NNP	dependence	dependence	depend	Y	O
(	(	(	(	(	N	O
9	CD	9	9	9	N	O
)]	NN	)]	)]	)]	N	O
.	.	.	.	.	N	O

5.6	CD	5.6	5.6	5.6	N	O
Suicidal	NNP	suicidal	suicidal	suicid	N	O
Behavior	NNP	behavior	behavior	behavior	N	O
and	CC	and	and	and	N	O
Ideation	NNP	ideation	ideation	ideat	N	O

Antiepileptic	JJ	antiepileptic	antiepileptic	antiepilept	N	O
drugs	NNS	drugs	drug	drug	N	O
(	(	(	(	(	N	O
AEDs	NNP	aeds	aeds	a	N	O
)	)	)	)	)	N	O
,	,	,	,	,	N	O
including	VBG	including	including	includ	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
,	,	,	,	,	N	O
increase	VB	increase	increase	increas	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	B-Factor
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thoughts	NNS	thoughts	thought	thought	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
in	IN	in	in	in	N	O
patients	NNS	patients	patient	patient	N	O
taking	VBG	taking	taking	take	N	O
these	DT	these	these	these	N	O
drugs	NNS	drugs	drug	drug	N	O
for	IN	for	for	for	N	O
any	DT	any	any	ani	N	O
indication	NN	indication	indication	indic	N	O
.	.	.	.	.	N	O

Patients	NNS	patients	patient	patient	N	O
treated	VBN	treated	treated	treat	N	O
with	IN	with	with	with	N	O
any	DT	any	any	ani	N	O
AED	NNP	aed	aed	a	N	O
for	IN	for	for	for	N	O
any	DT	any	any	ani	N	O
indication	NN	indication	indication	indic	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
monitored	VBN	monitored	monitored	monitor	N	O
for	IN	for	for	for	N	O
the	DT	the	the	the	N	O
emergence	NN	emergence	emergence	emerg	N	O
or	CC	or	or	or	N	O
worsening	NN	worsening	worsening	worsen	N	O
of	IN	of	of	of	N	O
depression	NN	depression	depression	depress	Y	O
,	,	,	,	,	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
or	CC	or	or	or	N	O
any	DT	any	any	ani	N	O
unusual	JJ	unusual	unusual	unusu	N	O
changes	NNS	changes	change	chang	N	O
in	IN	in	in	in	N	O
mood	NN	mood	mood	mood	N	O
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	O
.	.	.	.	.	N	O

Pooled	JJ	pooled	pooled	pool	N	O
analyses	NNS	analyses	analysis	analys	N	O
of	IN	of	of	of	N	O
199	CD	199	199	199	N	O
placebo	NN	placebo	placebo	placebo	N	O
-	:	-	-	-	N	O
controlled	VBN	controlled	controlled	control	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
(	(	(	(	(	N	O
mono	SYM	mono	mono	mono	N	O
-	:	-	-	-	N	O
and	CC	and	and	and	N	O
adjunctive	JJ	adjunctive	adjunctive	adjunct	N	O
therapy	NN	therapy	therapy	therapi	N	O
)	)	)	)	)	N	O
of	IN	of	of	of	N	O
11	CD	11	11	11	N	O
different	JJ	different	different	differ	N	O
AEDs	NNP	aeds	aeds	a	N	B-DrugClass
showed	VBD	showed	showed	show	N	O
that	IN	that	that	that	N	O
patients	NNS	patients	patient	patient	N	O
randomized	VBN	randomized	randomized	random	N	O
to	TO	to	to	to	N	O
one	CD	one	one	one	N	O
of	IN	of	of	of	N	O
the	DT	the	the	the	N	O
AEDs	NNP	aeds	aeds	a	N	O
had	VBD	had	had	had	N	O
approximately	RB	approximately	approximately	approxim	N	O
twice	RB	twice	twice	twice	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
(	(	(	(	(	N	O
adjusted	VBN	adjusted	adjusted	adjust	N	O
relative	NN	relative	relative	rel	N	O
risk	NN	risk	risk	risk	N	O
1.8	CD	1.8	1.8	1.8	N	O
,	,	,	,	,	N	O
95%	CD	95%	95%	95%	N	O
confidence	NN	confidence	confidence	confid	N	O
interval	NN	interval	interval	interv	N	O
[	NNP	[	[	[	N	O
CI	NNP	ci	ci	ci	N	O
]	NN	]	]	]	N	O
:	:	:	:	:	N	O
1.2	CD	1.2	1.2	1.2	N	O
,	,	,	,	,	N	O
2.7	CD	2.7	2.7	2.7	N	O
)	)	)	)	)	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thinking	NN	thinking	thinking	think	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
compared	VBN	compared	compared	compar	N	O
to	TO	to	to	to	N	O
patients	NNS	patients	patient	patient	N	O
randomized	VBN	randomized	randomized	random	N	O
to	TO	to	to	to	N	O
placebo	VB	placebo	placebo	placebo	N	O
.	.	.	.	.	N	O

In	IN	in	in	in	N	O
these	DT	these	these	these	N	O
trials	NNS	trials	trial	trial	N	O
,	,	,	,	,	N	O
which	WDT	which	which	which	N	O
had	VBD	had	had	had	N	O
a	DT	a	a	a	N	O
median	JJ	median	median	median	N	O
treatment	NN	treatment	treatment	treatment	N	O
duration	NN	duration	duration	durat	N	O
of	IN	of	of	of	N	O
12	CD	12	12	12	N	O
weeks	NNS	weeks	week	week	N	O
,	,	,	,	,	N	O
the	DT	the	the	the	N	O
estimated	VBN	estimated	estimated	estim	N	O
incidence	NN	incidence	incidence	incid	N	O
rate	NN	rate	rate	rate	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
or	CC	or	or	or	N	O
ideation	NN	ideation	ideation	ideat	N	I-AdverseReaction
among	IN	among	among	among	N	O
27	CD	27	27	27	N	O
,	,	,	,	,	N	O
863	CD	863	863	863	N	O
AED	NNP	aed	aed	a	N	B-DrugClass
treated	VBD	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
was	VBD	was	wa	wa	N	O
0.43%	CD	0.43%	0.43%	0.43%	N	O
,	,	,	,	,	N	O
compared	VBN	compared	compared	compar	N	O
to	TO	to	to	to	N	O
0.24%	CD	0.24%	0.24%	0.24%	N	O
among	IN	among	among	among	N	O
16	CD	16	16	16	N	O
,	,	,	,	,	N	O
029	CD	029	029	029	N	O
placebo	NN	placebo	placebo	placebo	N	O
treated	VBD	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
,	,	,	,	,	N	O
representing	VBG	representing	representing	repres	N	O
an	DT	an	an	an	N	O
increase	NN	increase	increase	increas	N	O
of	IN	of	of	of	N	O
approximately	RB	approximately	approximately	approxim	N	O
one	CD	one	one	one	N	O
case	NN	case	case	case	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thinking	NN	thinking	thinking	think	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
for	IN	for	for	for	N	O
every	DT	every	every	everi	N	O
530	CD	530	530	530	N	O
patients	NNS	patients	patient	patient	N	O
treated	VBN	treated	treated	treat	N	O
.	.	.	.	.	N	O

There	EX	there	there	there	N	O
were	VBD	were	were	were	N	O
four	CD	four	four	four	N	O
suicides	NNS	suicides	suicide	suicid	N	B-AdverseReaction
in	IN	in	in	in	N	O
drug	NN	drug	drug	drug	N	O
treated	VBN	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
trials	NNS	trials	trial	trial	N	O
and	CC	and	and	and	N	O
none	NN	none	none	none	N	O
in	IN	in	in	in	N	O
placebo	NN	placebo	placebo	placebo	N	O
treated	VBD	treated	treated	treat	N	O
patients	NNS	patients	patient	patient	N	O
,	,	,	,	,	N	O
but	CC	but	but	but	N	O
the	DT	the	the	the	N	O
number	NN	number	number	number	N	O
is	VBZ	is	is	is	N	O
too	RB	too	too	too	N	O
small	JJ	small	small	small	N	O
to	TO	to	to	to	N	O
allow	VB	allow	allow	allow	N	O
any	DT	any	any	ani	N	O
conclusion	NN	conclusion	conclusion	conclus	N	O
about	IN	about	about	about	N	O
drug	NN	drug	drug	drug	N	O
effect	NN	effect	effect	effect	N	O
on	IN	on	on	on	N	O
suicide	NN	suicide	suicide	suicid	Y	B-AdverseReaction
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
increased	VBN	increased	increased	increas	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thoughts	NNS	thoughts	thought	thought	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
with	IN	with	with	with	N	O
AEDs	NNP	aeds	aeds	a	N	B-DrugClass
was	VBD	was	wa	wa	N	O
observed	VBN	observed	observed	observ	N	O
as	RB	as	a	as	N	O
early	RB	early	early	earli	N	O
as	IN	as	a	as	N	O
one	CD	one	one	one	N	O
week	NN	week	week	week	N	O
after	IN	after	after	after	N	O
starting	VBG	starting	starting	start	N	O
drug	NN	drug	drug	drug	N	O
treatment	NN	treatment	treatment	treatment	N	O
with	IN	with	with	with	N	O
AEDs	NNP	aeds	aeds	a	N	O
and	CC	and	and	and	N	O
persisted	VBN	persisted	persisted	persist	N	O
for	IN	for	for	for	N	O
the	DT	the	the	the	N	O
duration	NN	duration	duration	durat	N	O
of	IN	of	of	of	N	O
treatment	NN	treatment	treatment	treatment	N	O
assessed	VBN	assessed	assessed	assess	N	O
.	.	.	.	.	N	O

Because	IN	because	because	becaus	N	O
most	JJS	most	most	most	N	O
trials	NNS	trials	trial	trial	N	O
included	VBD	included	included	includ	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
analysis	NN	analysis	analysis	analysi	N	O
did	VBD	did	did	did	N	O
not	RB	not	not	not	N	O
extend	VB	extend	extend	extend	N	O
beyond	IN	beyond	beyond	beyond	N	O
24	CD	24	24	24	N	O
weeks	NNS	weeks	week	week	N	O
,	,	,	,	,	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	B-Factor
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thoughts	NNS	thoughts	thought	thought	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	JJ	behavior	behavior	behavior	N	I-AdverseReaction
beyond	IN	beyond	beyond	beyond	N	O
24	CD	24	24	24	N	O
weeks	NNS	weeks	week	week	N	O
could	MD	could	could	could	N	O
not	RB	not	not	not	N	O
be	VB	be	be	be	N	O
assessed	VBN	assessed	assessed	assess	N	O
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	B-Factor
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thoughts	NNS	thoughts	thought	thought	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
was	VBD	was	wa	wa	N	O
generally	RB	generally	generally	gener	N	O
consistent	JJ	consistent	consistent	consist	N	O
among	IN	among	among	among	N	O
drugs	NNS	drugs	drug	drug	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
data	NNS	data	data	data	N	O
analyzed	VBD	analyzed	analyzed	analyz	N	O
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
finding	NN	finding	finding	find	N	O
of	IN	of	of	of	N	O
increased	VBN	increased	increased	increas	N	O
risk	NN	risk	risk	risk	N	O
with	IN	with	with	with	N	O
AEDs	NNP	aeds	aeds	a	N	O
of	IN	of	of	of	N	O
varying	VBG	varying	varying	vari	N	O
mechanisms	NNS	mechanisms	mechanism	mechan	N	O
of	IN	of	of	of	N	O
action	NN	action	action	action	N	O
and	CC	and	and	and	N	O
across	IN	across	across	across	N	O
a	DT	a	a	a	N	O
range	NN	range	range	rang	N	O
of	IN	of	of	of	N	O
indications	NNS	indications	indication	indic	N	O
suggests	VBZ	suggests	suggests	suggest	N	O
that	IN	that	that	that	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
applies	NNS	applies	applies	appli	N	O
to	TO	to	to	to	N	O
all	DT	all	all	all	N	O
AEDs	NNP	aeds	aeds	a	N	O
used	VBN	used	used	use	N	O
for	IN	for	for	for	N	O
any	DT	any	any	ani	N	O
indication	NN	indication	indication	indic	N	O
.	.	.	.	.	N	O

The	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
did	VBD	did	did	did	N	O
not	RB	not	not	not	N	O
vary	JJ	vary	vary	vari	N	O
substantially	RB	substantially	substantially	substanti	N	O
by	IN	by	by	by	N	O
age	NN	age	age	age	N	O
(	(	(	(	(	N	O
5	CD	5	5	5	N	O
-	:	-	-	-	N	O
100	CD	100	100	100	N	O
years	NNS	years	year	year	N	O
)	)	)	)	)	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
analyzed	VBD	analyzed	analyzed	analyz	N	O
.	.	.	.	.	N	O

Table	JJ	table	table	tabl	N	O
2	CD	2	2	2	N	O
shows	NNS	shows	show	show	N	O
absolute	NN	absolute	absolute	absolut	N	O
and	CC	and	and	and	N	O
relative	JJ	relative	relative	rel	N	O
risk	NN	risk	risk	risk	N	O
by	IN	by	by	by	N	O
indication	NN	indication	indication	indic	N	O
for	IN	for	for	for	N	O
all	DT	all	all	all	N	O
evaluated	JJ	evaluated	evaluated	evalu	N	O
AEDs	NNP	aeds	aeds	a	N	O
.	.	.	.	.	N	O

Table	JJ	table	table	tabl	N	O
2	CD	2	2	2	N	O
.	.	.	.	.	N	O

Risk	NN	risk	risk	risk	N	O
by	IN	by	by	by	N	O
Indication	NNP	indication	indication	indic	N	O
for	IN	for	for	for	N	O
Antiepileptic	NNP	antiepileptic	antiepileptic	antiepilept	N	O
Drugs	NNP	drugs	drug	drug	N	O
in	IN	in	in	in	N	O
the	DT	the	the	the	N	O
Pooled	NNP	pooled	pooled	pool	N	O
Analysis	NN	analysis	analysis	analysi	N	O

Indication	NNP	indication	indication	indic	N	O
Placebo	NNP	placebo	placebo	placebo	N	O
Patients	NNPS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
Events	NNS	events	event	event	N	O
per	IN	per	per	per	N	O
1000	CD	1000	1000	1000	N	O
Patients	NNS	patients	patient	patient	N	O
Drug	JJ	drug	drug	drug	N	O
Patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
Events	NNS	events	event	event	N	O
per	IN	per	per	per	N	O
1000	CD	1000	1000	1000	N	O
Patients	NNS	patients	patient	patient	N	O
Relative	JJ	relative	relative	rel	N	O
Risk	NN	risk	risk	risk	N	O
:	:	:	:	:	N	O
Incidence	NN	incidence	incidence	incid	N	O
of	IN	of	of	of	N	O
Drug	NNP	drug	drug	drug	N	O
Events	NNP	events	event	event	N	O
in	IN	in	in	in	N	O
Drug	NNP	drug	drug	drug	N	O
Patients	NNP	patients	patient	patient	N	O
Incidencein	NNP	incidencein	incidencein	incidencein	N	O
Placebo	NNP	placebo	placebo	placebo	N	O
Patients	NNP	patients	patient	patient	N	O
Risk	NNP	risk	risk	risk	N	O
Difference	NNP	difference	difference	differ	N	O
:	:	:	:	:	N	O
Additional	JJ	additional	additional	addit	N	O
Drug	NN	drug	drug	drug	N	O
Patients	NNS	patients	patient	patient	N	O
with	IN	with	with	with	N	O
Events	NNS	events	event	event	N	O
per	IN	per	per	per	N	O
1000	CD	1000	1000	1000	N	O
Patients	NNS	patients	patient	patient	N	O

Epilepsy	NNP	epilepsy	epilepsy	epilepsi	Y	O
1.0	CD	1.0	1.0	1.0	N	O
3.4	CD	3.4	3.4	3.4	N	O
3.5	CD	3.5	3.5	3.5	N	O
2.4	CD	2.4	2.4	2.4	N	O

Psychiatric	JJ	psychiatric	psychiatric	psychiatr	N	O
5.7	CD	5.7	5.7	5.7	N	O
8.5	CD	8.5	8.5	8.5	N	O
1.5	CD	1.5	1.5	1.5	N	O
2.9	CD	2.9	2.9	2.9	N	O

Other	JJ	other	other	other	N	O
1.0	CD	1.0	1.0	1.0	N	O
1.8	CD	1.8	1.8	1.8	N	O
1.9	CD	1.9	1.9	1.9	N	O
0.9	CD	0.9	0.9	0.9	N	O

Total	JJ	total	total	total	N	O
2.4	CD	2.4	2.4	2.4	N	O
4.3	CD	4.3	4.3	4.3	N	O
1.8	CD	1.8	1.8	1.8	N	O
1.9	CD	1.9	1.9	1.9	N	O

The	DT	the	the	the	N	O
relative	JJ	relative	relative	rel	N	O
risk	NN	risk	risk	risk	N	B-Factor
for	IN	for	for	for	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	B-AdverseReaction
thoughts	NNS	thoughts	thought	thought	N	I-AdverseReaction
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	I-AdverseReaction
was	VBD	was	wa	wa	N	O
higher	RBR	higher	higher	higher	N	O
in	IN	in	in	in	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
for	IN	for	for	for	N	O
epilepsy	NN	epilepsy	epilepsy	epilepsi	Y	O
than	IN	than	than	than	N	O
in	IN	in	in	in	N	O
clinical	JJ	clinical	clinical	clinic	N	O
trials	NNS	trials	trial	trial	N	O
for	IN	for	for	for	N	O
psychiatric	JJ	psychiatric	psychiatric	psychiatr	N	O
or	CC	or	or	or	N	O
other	JJ	other	other	other	N	O
conditions	NNS	conditions	condition	condit	N	O
,	,	,	,	,	N	O
but	CC	but	but	but	N	O
the	DT	the	the	the	N	O
absolute	NN	absolute	absolute	absolut	N	O
risk	NN	risk	risk	risk	N	O
differences	NNS	differences	difference	differ	N	O
were	VBD	were	were	were	N	O
similar	JJ	similar	similar	similar	N	O
for	IN	for	for	for	N	O
the	DT	the	the	the	N	O
epilepsy	NN	epilepsy	epilepsy	epilepsi	Y	O
and	CC	and	and	and	N	O
psychiatric	JJ	psychiatric	psychiatric	psychiatr	N	O
indications	NNS	indications	indication	indic	N	O
.	.	.	.	.	N	O

Anyone	NN	anyone	anyone	anyon	N	O

considering	VBG	considering	considering	consid	N	O
prescribing	VBG	prescribing	prescribing	prescrib	N	O
ONFI	NNP	onfi	onfi	onfi	N	O
or	CC	or	or	or	N	O
any	DT	any	any	ani	N	O
other	JJ	other	other	other	N	O
AED	NNP	aed	aed	a	N	O
must	MD	must	must	must	N	O
balance	VB	balance	balance	balanc	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	O
with	IN	with	with	with	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
untreated	JJ	untreated	untreated	untreat	N	O
illness	NN	illness	illness	ill	N	O
.	.	.	.	.	N	O

Epilepsy	NNP	epilepsy	epilepsy	epilepsi	Y	O
and	CC	and	and	and	N	O
many	JJ	many	many	mani	N	O
other	JJ	other	other	other	N	O
illnesses	NNS	illnesses	illness	ill	N	O
for	IN	for	for	for	N	O
which	WDT	which	which	which	N	O
AEDs	NNP	aeds	aeds	a	N	O
are	VBP	are	are	are	N	O
prescribed	VBN	prescribed	prescribed	prescrib	N	O
are	VBP	are	are	are	N	O
themselves	PRP	themselves	themselves	themselv	N	O
associated	VBN	associated	associated	associ	N	O
with	IN	with	with	with	N	O
morbidity	NN	morbidity	morbidity	morbid	N	O
and	CC	and	and	and	N	O
mortality	NN	mortality	mortality	mortal	N	O
and	CC	and	and	and	N	O
an	DT	an	an	an	N	O
increased	VBN	increased	increased	increas	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
and	CC	and	and	and	N	O
behavior	NN	behavior	behavior	behavior	N	O
.	.	.	.	.	N	O

Should	MD	should	should	should	N	O
suicidal	VB	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
and	CC	and	and	and	N	O
behavior	JJ	behavior	behavior	behavior	N	O
emerge	NN	emerge	emerge	emerg	N	O
during	IN	during	during	dure	N	O
treatment	NN	treatment	treatment	treatment	N	O
,	,	,	,	,	N	O
the	DT	the	the	the	N	O
prescriber	NN	prescriber	prescriber	prescrib	N	O
needs	VBZ	needs	need	need	N	O
to	TO	to	to	to	N	O
consider	VB	consider	consider	consid	N	O
whether	IN	whether	whether	whether	N	O
the	DT	the	the	the	N	O
emergence	NN	emergence	emergence	emerg	N	O
of	IN	of	of	of	N	O
these	DT	these	these	these	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
in	IN	in	in	in	N	O
any	DT	any	any	ani	N	O
given	VBN	given	given	given	N	O
patient	NN	patient	patient	patient	N	O
may	MD	may	may	may	N	O
be	VB	be	be	be	N	O
related	VBN	related	related	relat	N	O
to	TO	to	to	to	N	O
the	DT	the	the	the	N	O
illness	NN	illness	illness	ill	N	O
being	VBG	being	being	be	N	O
treated	VBN	treated	treated	treat	N	O
.	.	.	.	.	N	O

Patients	NNS	patients	patient	patient	N	O
,	,	,	,	,	N	O
their	PRP$	their	their	their	N	O
caregivers	NNS	caregivers	caregiver	caregiv	N	O
,	,	,	,	,	N	O
and	CC	and	and	and	N	O
families	NNS	families	family	famili	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
informed	VBN	informed	informed	inform	N	O
that	IN	that	that	that	N	O
AEDs	NNP	aeds	aeds	a	N	O
increase	VB	increase	increase	increas	N	O
the	DT	the	the	the	N	O
risk	NN	risk	risk	risk	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
and	CC	and	and	and	N	O
behavior	NN	behavior	behavior	behavior	N	O
and	CC	and	and	and	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
advised	VBN	advised	advised	advis	N	O
of	IN	of	of	of	N	O
the	DT	the	the	the	N	O
need	NN	need	need	need	N	O
to	TO	to	to	to	N	O
be	VB	be	be	be	N	O
alert	JJ	alert	alert	alert	N	O
for	IN	for	for	for	N	O
the	DT	the	the	the	N	O
emergence	NN	emergence	emergence	emerg	N	O
or	CC	or	or	or	N	O
worsening	NN	worsening	worsening	worsen	N	O
of	IN	of	of	of	N	O
the	DT	the	the	the	N	O
signs	NNS	signs	sign	sign	N	O
and	CC	and	and	and	N	O
symptoms	NNS	symptoms	symptom	symptom	N	O
of	IN	of	of	of	N	O
depression	NN	depression	depression	depress	Y	O
,	,	,	,	,	N	O
any	DT	any	any	ani	N	O
unusual	JJ	unusual	unusual	unusu	N	O
changes	NNS	changes	change	chang	N	O
in	IN	in	in	in	N	O
mood	NN	mood	mood	mood	N	O
or	CC	or	or	or	N	O
behavior	NN	behavior	behavior	behavior	N	O
,	,	,	,	,	N	O
or	CC	or	or	or	N	O
the	DT	the	the	the	N	O
emergence	NN	emergence	emergence	emerg	N	O
of	IN	of	of	of	N	O
suicidal	JJ	suicidal	suicidal	suicid	N	O
thoughts	NNS	thoughts	thought	thought	N	O
,	,	,	,	,	N	O
behavior	NN	behavior	behavior	behavior	N	O
,	,	,	,	,	N	O
or	CC	or	or	or	N	O
thoughts	NNS	thoughts	thought	thought	N	O
about	IN	about	about	about	N	O
self	PRP	self	self	self	N	O
-	:	-	-	-	N	O
harm	NN	harm	harm	harm	N	O
.	.	.	.	.	N	O

Behaviors	NNS	behaviors	behavior	behavior	N	O
of	IN	of	of	of	N	O
concern	NN	concern	concern	concern	N	O
should	MD	should	should	should	N	O
be	VB	be	be	be	N	O
reported	VBN	reported	reported	report	N	O
immediately	RB	immediately	immediately	immedi	N	O
to	TO	to	to	to	N	O
healthcare	VB	healthcare	healthcare	healthcar	N	O
providers	NNS	providers	provider	provid	N	O
.	.	.	.	.	N	O

